Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and prior anti-tumor therapy: A subanalysis from the sharp trial

被引：9
|
作者：
Galle, P. [1 ]
Blanc, J. [2 ]
Van Laethem, J-L. [3 ]
Marrero, J. [4 ]
Beaugrand, M. [5 ]
Moscovici, M. [6 ]
Shan, M. [7 ]
Nadel, A. [7 ]
Voliotis, D. [8 ]
Bruix, J. [9 ]
Llovet, J. M. [9 ,10 ]
机构：
[1] Univ Mainz Klinikum, Mainz, Germany
[2] CHU, Hop St Andre, Bordeaux, France
[3] Erasme Univ Hosp, B-1070 Brussels, Belgium
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Hop Jean Verdier, Bondy, France
[6] Bayer Schering Pharma, Milan, Italy
[7] Bayer Healthcare Pharmaceut, West Haven, CT USA
[8] Bayer Schering Pharma, Global Clin Dev, Wuppertal, Germany
[9] Hosp Clin Barcelona, Liver Unit, CIBERehd, IDIBAPS,BCLC Grp, Barcelona, Spain
[10] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 48卷
关键词：
D O I：
10.1016/S0168-8278(08)60996-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
994
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [31] Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
    Nakano, Masahito
    Tanaka, Masatoshi
    Kuromatsu, Ryoko
    Nagamatsu, Hiroaki
    Sakata, Kenji
    Matsugaki, Satoru
    Kajiwara, Masahiko
    Fukuizumi, Kunitaka
    Tajiri, Nobuyoshi
    Matsukuma, Norito
    Sakai, Terufumi
    Ono, Noriyuki
    Yano, Yoichi
    Koga, Hironori
    Kurogi, Junichi
    Takata, Akio
    Sumie, Shuji
    Satani, Manabu
    Yamada, Shingo
    Niizeki, Takashi
    Aino, Hajime
    Iwamoto, Hideki
    Torimura, Takuji
    Sata, Michio
    ONCOLOGY, 2013, 84 (02) : 108 - 114
  • [32] Sorafenib-irinotecan sequential therapy augmented the anti-tumor efficacy of monotherapy in hepatocellular carcinoma cells HepG2
    Wang, Z.
    Zhao, Z.
    Wu, T.
    Song, L.
    Zhang, Y.
    NEOPLASMA, 2015, 62 (02) : 172 - 179
  • [33] Efficacy and safety of localized concurrent chemoradiation therapy and sorafenib sequential therapy in advanced hepatocellular carcinoma: A prospective phase II trial.
    Kim, Beom Kyung
    Kim, Do Young
    Choi, Hye Jin
    Beom, Seung-Hoon
    Lee, Hye Won
    Kim, Seung Up
    Park, Jun Yong
    Ahn, Sang Hoon
    Seong, Jinsil
    Han, Kwang-Hyub
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Efficacy and safety of nintedanib vs sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomised Phase II trial
    Yen, C.
    Kim, T. Y.
    Feng, Y. H.
    Chao, Y.
    Lin, D. Y.
    Studeny, M.
    Hocke, J.
    Huang, D. C. L.
    Ryoo, B. Y.
    Cheng, A. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S612 - S612
  • [35] Randomized phase II trial comparing the efficacy and safety of nintedanib versus sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Palmer, Daniel H.
    Ma, Yuk Ting
    Peck-Radosavljevic, Markus
    Ross, Paul J.
    Graham, Janet Shirley
    Fartoux, Laetitia
    Deptala, Andrzej
    Wenz, Arne
    Hocke, Julia
    Loembe, Arsene-Bienvenu
    Meyer, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [36] Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma
    Ogasawara, Sadahisa
    Kanai, Fumihiko
    Obi, Shuntaro
    Sato, Shinpei
    Yamaguchi, Taketo
    Azemoto, Ryosaku
    Mizumoto, Hideaki
    Koushima, Youhei
    Morimoto, Naoki
    Hirata, Nobuto
    Toriyabe, Takeshi
    Shinozaki, Yusuke
    Ooka, Yoshihiko
    Mikata, Rintaro
    Chiba, Tetsuhiro
    Okabe, Shinichiro
    Imazeki, Fumio
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    HEPATOLOGY INTERNATIONAL, 2011, 5 (03) : 850 - 856
  • [37] Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma
    Sadahisa Ogasawara
    Fumihiko Kanai
    Shuntaro Obi
    Shinpei Sato
    Taketo Yamaguchi
    Ryosaku Azemoto
    Hideaki Mizumoto
    Youhei Koushima
    Naoki Morimoto
    Nobuto Hirata
    Takeshi Toriyabe
    Yusuke Shinozaki
    Yoshihiko Ooka
    Rintaro Mikata
    Tetsuhiro Chiba
    Shinichiro Okabe
    Fumio Imazeki
    Masaharu Yoshikawa
    Osamu Yokosuka
    Hepatology International, 2011, 5 : 850 - 856
  • [38] Efficacy and tolerability of sorafenib in elderly patients with advanced hepatocellular carcinoma
    Wong, H.
    Yau, C. C.
    Yao, T.
    Tang, V.
    Chan, P.
    Chiu, J.
    Fan, S.
    Peon, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis
    Schuette, Kerstin
    Zimmermann, Lars
    Bornschein, Jan
    Csepregi, Antal
    Ruehl, Ricarda
    Ricke, Jens
    Malfertheiner, Peter
    DIGESTION, 2011, 83 (04) : 275 - 282
  • [40] Single-Center Study of Safety and Anti-tumor Activity of Nivolumab in Patients with Advanced Hepatocellular Carcinoma or Cholangiocarcinoma
    Soe, Eiei P.
    Gu, Ping
    Park, James
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1262 - S1262
12345